Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
Torex Gold Resources (TSE:TXG) Shares Cross Above 200-Day Moving Average – Here’s Why
03:25am, Tuesday, 03'rd Feb 2026
Torex Gold Resources Inc. (TSE: TXG - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of C$58.31 and traded as
Head-To-Head Survey: 10x Genomics (NASDAQ:TXG) & Azenta (NASDAQ:AZTA)
01:46am, Saturday, 31'st Jan 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on th
SG Americas Securities LLC Sells 40,241 Shares of 10x Genomics $TXG
04:56am, Sunday, 25'th Jan 2026
SG Americas Securities LLC trimmed its stake in shares of 10x Genomics (NASDAQ: TXG) by 50.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commiss
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
04:05pm, Thursday, 22'nd Jan 2026
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
10:56am, Wednesday, 21'st Jan 2026
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Inscription Capital LLC Acquires 59,305 Shares of 10x Genomics $TXG
04:45am, Wednesday, 21'st Jan 2026
Inscription Capital LLC grew its holdings in shares of 10x Genomics (NASDAQ: TXG) by 161.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchang
Cathie Wood's Ark Invest unveiled its "big ideas" for 2025 in a cryptic list, challenging users to interpret a series of custom images called "ARKmoji" to understand their picks for the year.
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
09:11am, Monday, 12'th Jan 2026
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc.
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
09:10am, Monday, 12'th Jan 2026
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to pow
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
09:00am, Monday, 12'th Jan 2026
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generati
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
12:00pm, Sunday, 11'th Jan 2026
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth qu
Torex Gold Resources (TSE:TXG) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened
03:55am, Thursday, 08'th Jan 2026
Torex Gold Resources Inc. (TSE: TXG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$54.40 and traded
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
07:05am, Wednesday, 07'th Jan 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of cl
Critical Analysis: United Treatment Centers (OTCMKTS:POTN) & 10x Genomics (NASDAQ:TXG)
01:58am, Saturday, 03'rd Jan 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and United Treatment Centers (OTCMKTS:POTN - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two bu
Financial Consulate Inc. Acquires New Holdings in 10x Genomics $TXG
04:27am, Friday, 02'nd Jan 2026
Financial Consulate Inc. bought a new position in shares of 10x Genomics (NASDAQ: TXG) during the undefined quarter, according to its most recent 13F filing with the SEC. The firm bought 156,457 share
